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Slovak Academy of Sciences, Bratislava, Slovakia; and §Department of Experimental Medicine, University of Milano Bicocca, Monza, ItalyABSTRACT To explore the initial stages of amyloid b peptide (Ab42) deposition on membranes, we have studied the interac-
tion of Ab42 in themonomeric form with lipid monolayers and with bilayers in either the liquid-disordered or the liquid-ordered (Lo)
state, containing negatively charged phospholipids. Molecular dynamics (MD) simulations of the system have been performed,
as well as experimental measurements. For bilayers in the Lo state, in the absence of the negatively charged lipids, interaction
is weak and it cannot be detected by isothermal calorimetry. However, in the presence of phosphatidic acid, or of cardiolipin,
interaction is detected by different methods and in all cases interaction is strongest with lower (2.5–5 mol %) than higher
(10–20 mol %) proportions of negatively charged phospholipids. Liquid-disordered bilayers consistently allowed a higher
Ab42 binding than Lo ones. Thioflavin T assays and infrared spectroscopy confirmed a higher proportion of b-sheet formation
under conditions when higher peptide binding was measured. The experimental results were supported by MD simulations.
We used 100 ns MD to examine interactions between Ab42 and three different 512 lipid bilayers consisting of palmitoylsphin-
gomyelin, dimyristoyl phosphatidic acid, and cholesterol in three different proportions. MD pictures are different for the low- and
high-charge bilayers, in the former case the peptide is bound through many contact points to the bilayer, whereas for the bilayer
containing 20 mol % anionic phospholipid only a small fragment of the peptide appears to be bound. The MD results indicate that
the binding and fibril formation on the membrane surface depends on the composition of the bilayer, and is the result of a subtle
balance of many inter- and intramolecular interactions between the Ab42 and membrane.INTRODUCTIONAlzheimer’s disease (AD) is a late-onset neurological
disorder with progressive loss of memory and cognitive
abilities as a result of excessive neurodegeneration (1).
AD is characterized by extracellular aggregates of
b-amyloid (Ab) peptides known as amyloid plaques (2).
The Ab peptide is derived from the sequential processing
of the amyloid precursor protein (APP) by b- and g-secre-
tases. Nonamyloidogenic processing of APP involves a-sec-
retase that cleaves APP inside the Ab region precluding Ab
formation (3). Lateral organization of membranes (4) and
subcellular localization (5) of the substrate and the secre-
tases has been documented to regulate Ab generation.
Previous work suggests that b-secretase associates with
liquid-ordered (Lo) microdomains in the membrane (6,7)
and that integrity of those (raft) domains is required for
b-cleavage of APP to occur. Cleavage by a-secretase, in
contrast, would occur outside the Lo microdomains (4).
Ab peptide is released from cells in a soluble form, and
progressively undergoes aggregation forming oligomers,
multimers, and fibrils, ending with deposition of extracel-
lular plaques (8). Oligomers have been indicated as theSubmitted January 14, 2012, and accepted for publication June 27, 2012.
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0006-3495/12/08/0453/11 $2.00most toxic Ab species (9), appearing likely before plaque
deposition at an early stage of AD pathology. However,
protofibrillar and fibrillar aggregates were also shown to
be toxic (10,11). The structure of the Ab peptide, along its
passage from monomer to small aggregate to fibril, has
been a subject of great interest for both experimental
(12,13) and computational (14,15) researchers. Some
workers have proposed (16) that free radical formation
would be an essential factor in amyloidogenic Ab aggrega-
tion. A recent study shows that lysophosphatidylcholine
micelles enhance the formation of Ab42 fibrils (17).
The toxicity of Ab peptide appears to require conversion
of the monomeric form to an aggregated fibrillar species.
Although it is clear that the first stages of Ab aggregation
are essential to the progress of AD, it has not yet been
determined exactly what factors influence this initial
conversion from monomer to oligomer. Recent work
(12,13) has demonstrated that cell membranes may play
a significant catalytic role in increasing Ab aggregation
rates. Experimental work (12–16) has shown that Ab,
when interacting with lipid vesicles of various composi-
tions, especially anionic lipids, will aggregate at a much
faster rate than in solution. Further results have shown
that this interaction between Ab and lipids will induce
a structural conversion (12–16) from a disordered peptide
into a peptide dominated by b-structure. Various reports
(18,19) show that anionic lipids promote fibril elongation.http://dx.doi.org/10.1016/j.bpj.2012.06.043
454 Ahyayauch et al.However, a quantitative description of the interaction of
essentially monomeric Ab peptide with phospholipid
membranes is not yet available.
Computational methods have been extensively used to
describe the conformational behavior of Ab peptides in
aqueous solution. They have provided valuable insight
into the structure of Ab in different steps of aggregation.
However, only a few studies (20,21) investigated the Ab42
structure bound on the bilayer surface, whereas others
(22,23) studied the stability and structure of Ab inserted
into membrane. Davies and Berkowitz (20,21) examined
Ab42-phospholipid bilayer interactions using molecular
dynamics (MD) simulations. The results showed that
Ab42 is attracted to the lipid surface during simulations
regardless of the Ab42 charge or the membrane charge. In
their second study (21), the authors used replica exchange
MD and observed that Ab42 exhibits significant conforma-
tional flexibility on the membrane surface.
In this work both biophysical and computational tech-
niques have been used to elucidate the molecular and struc-
tural details of the initial stages of Ab monomer-membrane
interaction. In MD simulations, we have investigated the
structure of Ab42 close to the surface of heterogeneous bila-
yers consisting of palmitoylsphingomyelin (PSM), dimyris-
toyl phosphatidic acid (DMPA), and cholesterol (Chol) in
different proportions. In experiments, we have used large
unilamellar vesicles (LUVs) and monolayers composed
of lipids giving rise (in bilayers) to Lo phases, because
b-secretase cleavage is believed to occur mainly in Lo
domains (6,7), and occasionally we have used lipids giving
rise to liquid-disordered (Ld) phases, predominant in cell
membranes. Negatively charged phospholipids have been
added to the lipid compositions to confirm the role of these
lipids in bilayer-peptide interaction. Isothermal titration
calorimetry (ITC), Langmuir monolayer experiments, thio-
flavin T (ThT) assays, infrared (IR) spectroscopy, and MD
simulations have been performed, with good agreement
between the computational and experimental results.EXPERIMENTAL PROCEDURES
Due to space limitations experimental procedures are described in detail in
the Supporting Material.MD simulations
Initial coordinates for Ab42 were based on the NMR structure (24) deter-
mined in aqueous solutions of fluorinated alcohols. This three-dimensional
NMR structure shows two helical regions encompassing residues 8–25 and
28–38, connected by a typical type I b-turn (pdb code 1IYT). The Ab42
structure has been constructed in the Maestro interface of the Schro¨dinger
program (Schro¨dinger LLC, New York, NY). The structure was submitted
to the protein preparation utility, which included bond order correction,
hydrogen addition, and subsequent optimization in the OPLS-AA force
field (26). Ab42 was modeled as a zwitterionic structure, with ionized
C-, and N-terminus of the peptide. The force field parameters of Ab42
were based on GROMOS 96 (27).Biophysical Journal 103(3) 453–463Three models of the 512 lipid bilayer consisting of PSM, DMPA, and
Chol in three different proportions were used for our simulations (more
details in the Supporting Material data).Experimental studies
Materials
Ab42 was supplied by Mario Negri Institute (Milan, Italy), a partner in the
European Union Project (FP7/2007-2013), 1,1,1,3,3,3-hexafluoro-2-propa-
nol and ThT were purchased from Sigma (St. Louis, MO). Brain sphingo-
myelin (SM), DMPA, bovine heart cardiolipin (CL), and cholesterol were
purchased from Avanti Polar Lipids (Alabaster, AL). Egg phosphatidyl
choline (PC) was from Lipid Products (South Nutfield, United Kingdom).
Ab42 sample preparation
Ab42 stock solution was prepared by dissolving the peptide at 1 mg/ml in
1,1,1,3,3,3-hexafluoro-2-propanol to render monomeric Ab42. The volatile
solvent was removed under vacuum in a Speed Vac (ThermoSavant,
Holbrook, NY). The predominant monomeric form at least in the first 6 h
after preparation was checked by ThT fluorescence (28) (Fig. S1 in the
Supporting Material). ITC experiments took 5 h on average; other measure-
ments were completed in <1 h.
Preparation of LUV
LUVs were prepared as described (29).
ITC
ITC was performed as described in detail by Arnulphi et al. (30).
Lipid monolayer measurements
Monolayers at the air-water interface in a Langmuir balance were studied at
22C as indicated (31).
ThT assay
ThT fluorescence was performed as described (28).
IR spectroscopy measurements
See Methods in the Supporting Material.RESULTS
MD simulations
To characterize in more detail the conformational behavior
of Ab42 at the bilayer surface, an analysis of the Ab42
secondary structure along the MD simulation trajectory
was performed. The profile of secondary changes of Ab42
and several snapshots extracted from the A–C trajectories
are shown in Fig. 1. Fig. S2 illustrates the orientation and
structure of the most frequently occurring conformations
of Ab42 during the simulations. The A model (PSM/Chol/
DMPA¼ 50:50:0) provides reference data on a role of nega-
tively charged phospholipids on conformational dynamics
of Ab42. In this model, shown in Fig. 1, during the 50 ns
simulation the initial helical conformation of the Ab42
segments does not undergo significant changes. The 10–
20, and to some extent 5–10 regions, remain helical for
the time of the simulation and b-sheet structures are not
FIGURE 1 Time evolution of the Ab42 peptide
secondary structure in models A (SM/Chol/
DMPA ¼ 50:50:0), B (47.5:47.5:5.0), and C
(40:40:20). The secondary structures were calcu-
lated by the DSSP program (50). The snapshot
structures of Ab42 were taken from trajectories at
20-ns intervals.
Binding of Ab42 Peptide to Negatively Charged Membranes 455observed. Therefore, we did not extend simulation time
to 100 ns. A conserved pattern of secondary structure is
shown, indicating a strong intramolecular hydrogen bond
network in the protein. In the B model, PSM/Chol/
DMPA ¼ 47.5:47.5:5.0, the secondary structure motif
changes to mostly unordered coil conformation after 25 ns
simulation, but after that Ab42 is able to adopt conforma-
tions containing more ordered secondary structure. Remark-
ably, after 85 ns the segment of residues 10–18 starts to
develop a b-sheet structure, which is stable to the end of
the simulation. The simulation snapshots shown in Fig. S2
were clustered based on the root mean-square of Ab42
backbone residual distances. The results revealed that the
single most common conformation occurs in 28.7% of thetrajectory. The second most common structure cluster
contained only 1.6% of the snapshots. Fig S2 shows that
the prevailing cluster of Ab42 is tightly bound on the
membrane surface in the B model. The peptide secondary
structure resembles surprisingly the b-hairpin conformation
of the Ab42 fibril. The connection of the Ab-surface associ-
ation and the formation of the b-sheet structures that could
promote aggregation has been indicated previously (21). On
the contrary, in model C with the bilayer composition PSM/
Chol/DMPA ¼ 40:40:20, after the initial loss of the helical
structure and beginning at 20 ns simulation, the segment of
residues 12–20 builds up a 5-helical conformation that is
stable for the rest of the 100 ns simulation trajectory. The
residues 30–35 adopted an a-helical conformation in theBiophysical Journal 103(3) 453–463
FIGURE 2 Time evolution of the MD simulations in the model A (SM/
Chol/DMPA ¼ 50:50:0), B (47,5:47.5:5.0), and C (40:40:20). For the
sake of clarity, the data were averaged every 20 ps. (A) Average area per
lipid molecule. (B) Hydrogen bonds between Ab42 and membrane phos-
pholipids. The proton donor-acceptor distance threshold was 0.35 nm and
the angle was 30. (C) Radius of gyration of the Ab42 peptide in all models.
456 Ahyayauch et al.trajectory interval 25–70 ns. Clustering analysis revealed the
existence of a single most prevailing Ab42 structure, shown
in Fig S2, with an occurrence of 46.6% of the trajectory, the
second most common structure has an occurrence of 2.6%.
The conformational transitions of Ab42 are also reflected
in values of the radius of gyration as a result of interactions
with the phospholipid membrane. See Fig. 2 C, which shows
the calculated radius of gyration of Ab42 during the simula-
tion in all three models. In model B the radius of gyration
varies between 1.4 and 2 nm during the simulation, whereas
in model A and C, it is much lower and more uniform
at ~1 nm. These differences between the models indicate
a different conformational behavior of the Ab42 peptide.
One of the most common parameters describing the
lipidic bilayer properties is the area per lipid headgroup.
Here, we have calculated the average area per lipid head-
group (Alipid) for fully hydrated 512 lipid bilayers during
the MD simulations simply as the product of the box dimen-
sions in the x axis and y axis, divided by the lipid number in
a single leaflet (Fig. 2 A.). After the initial 10 ns, the Alipid in
all simulations varies within 0.05 nm2, indicating that the
bilayer model is sufficiently equilibrated. In model A, the
Alipid is lower compared to the B model, and the Alipid of
the model C is ~0.2 nm2 higher than in the model B. The
results from our three bilayer models averaged over the
last 50 ns of simulation give 0.379, 0.386, and 0.401nm2
for the A, B, and C models, respectively. This was expected,
because the ratio of the cholesterol molecules in model A
and B is larger than in model C. The averaged values are
clearly lower than the calculated values of the individual
constituents in our system. For the 1-palmitoyl-2-oleoyl
phosphatidic acid, similar to DMPA, values ranging from
0.485 to 0.511 nm2 were reported (32). For PSM, values
from 0.565 to 0.59 nm2 were obtained by Mombelli et al.
(33), and for Chol the experimentally obtained Alipid is
0.39 nm2 (32). However, in a mixture with phospholipids
the condensation effect of cholesterol is well known (34).
They observed an average Alipid of 0.39 nm
2 in a 1:1 mixture
of Chol and dipalmitoylphosphatidylcholine (DPPC), which
corresponds well with our models.
Among many of the inter- and intramolecular interactions
between Ab42 and the membrane surface, hydrogen bonds
play an important role and may be involved in the formation
of Ab42 fibrils. Therefore, the number of hydrogen bonds
between Ab42 amino acids and membrane lipids, represent-
ing interactions of Ab42 with the phospholipid membrane
surface was calculated as a function of time (Fig. 2 B).
The evolution of the hydrogen bond contacts shows clearly
more interactions in model B, gradually evolving during the
simulations, with up to 25 interactions after 70 ns. In the
case of model C, the number of interactions is lower, with
up to 12 hydrogen bond contacts after 90 ns simulation.
On the contrary, no hydrogen bonds have been observed
in model A for the time of the simulation. We note that all
simulations started from a structure with no hydrogenBiophysical Journal 103(3) 453–463bond interactions between Ab42 and the membrane. To
analyze the contribution of individual Ab42 amino acids
to the hydrogen bonding network with the membrane the
relative occurrence of hydrogen bonds for each residue
has been calculated (Fig. 3). The B model is characterized
by multiple interactions between Ab42 and PSM, whereas
the hydrogen bonds to Chol are scarce and those to
DMPA, negligible. The peptide region mostly involved in
FIGURE 3 Hydrogen bond occurrence between the residues of Ab42 and
membrane lipids in the models B and C. Distance and angle threshold
between the hydrogen bond donor and acceptor was 0.35 nm and 30,
respectively. Relative occurrences for multivalent interactions are summed
to individual residues.
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The hydrophilic part that contributes to the interactions
involves residues Asp-1, Ala-2, Arg-5, and residues
24–28. Of importance, the prevailing binding residue is
Lys-28, with multiple interactions with PSM and some to
Chol. The crucial role of Lys-28 in binding to bilayer phos-
pholipids has been suggested earlier (21,35), and our model
is in agreement with those results. The number of interacting
Ab42 residues in model C is much smaller. As expected, due
to the higher DMPA concentration, the hydrogen bonds to
DMPA are more common than in model B. Here, the most
occurring binding residue is Asp-1, interacting dominantly
with PSM and to some extent also with DMPA. Hydrophilic
residues Arg-5, Ser-26, Asn-27, and Lys-28 show interac-
tions with DMPA, and less to PSM. It is noteworthy that
Lys-28 is the second most involved binding residue in this
model. The region of residues 29–42 do not interact with
the membrane. Fig. S3 summarizes these results.(mN/m)
FIGURE 4 Changes in surface pressure of lipid monolayers, upon inser-
tion of Ab42 monomers at varying initial pressures. (A) A representative
experiment, obtained with SM/Chol/DMPA (40/40/20) at 15 mN/m.
(B) Equilibrium values. C, SM/Chol (1:1), :, SM/Chol/DMPA (47.5/
47.5/5), -, SM/Chol/DMPA (40/40/20). Average values mean 5 SE
(n ¼ 3). Ab42 stock solution was 50 mM. Ab42 final concentration in the
trough was 1.22 mM.Experimental measurements
Lipid monolayers at the air-water interface
The surface active properties of Ab42 and its monomeric
interaction with membrane lipids were first tested in a Lang-
muir balance at the air-water interface. In the absence oflipids, injection of Ab42 into the aqueous phase causes an
increase in surface pressure, the latter reaching equilibrium
after z1 h (Fig. S4 A). This shows that Ab42 is surface
active, like many other peptides (31). The increase in
surface pressure is dose-dependent and reaches a plateau
at ~10 mN/m, for Ab concentrations slightly above 1 mM
(Fig. S4 B). Thus, at these and higher concentrations the
interface is saturated with adsorbed peptide and the peptide
partitions between the interface and the bulk water (31).
Previous studies have found plateau values in the
12–17 mN/m range with Ab42 or Ab40 (36–39), the origin
of the variability being unclear at present.
Ab insertion into lipid monolayers was assayed in
a different set of experiments, in which a lipid monolayer
was extended at the air-water interface and the peptide
was injected into the aqueous subphase. The initial surface
pressure of the lipid monolayer was fixed as desired, at
values >10 mN/m to avoid simultaneous peptide insertion
and peptide adsorption. Ab insertion into the lipid mono-
layer at the interface causes a further increase in surface
pressure Dp (Fig. 4 A). As the initial pressure increases,
Dp decreases (Fig. 4 B) until a point is reached, at
30–33 mN/m for this system, at which peptide insertion isBiophysical Journal 103(3) 453–463
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458 Ahyayauch et al.no longer possible. Fig. 4 B includes results for three
different lipid compositions in the monolayer. In the
10–30 mN/m range, peptide insertion becomes easier in
the order: SM/Chol (1:1) < SM/Chol/DMPA (40:40:20) <
SM/Chol/DMPA (47.5:47.5:5), all figures given as mole
ratios. However, the limiting initial pressure for all three
lipid compositions is the same, close to 30 mN/m, and is
supposed to be (with large fluctuations) the average surface
pressure in the cell membranes. The same limiting initial
pressure of 30 mN/m was found by Maltseva et al. (37,38)
for Ab40. This may mean that, under the cellular conditions,
Ab exists in equilibrium between the free and membrane-
bound forms. The fact that insertion is facilitated by the
presence of negatively charged lipids in the monolayer
supports the role of electrostatic interactions in stabilizing
Ab42 insertion into lipid monolayers, in agreement with
previous suggestions (37,39). A compression isotherm of
the SM/Chol/DMPA (40/40/20) mixture indicated an
average area/molecule of z 0.4 nm2, in agreement with
the MD calculations (isotherm not shown).
The physical state of lipid bilayers containing DMPA
The SM/Chol/DMPA bilayers under study are in the Lo
phase. Egg PC and PC/DMPA bilayers exist in the Ld phase
(see the Supporting Material and Fig. S5).
Calorimetric studies
Small amounts of LUV were added to an Ab solution
and measurement of heat exchanges at varying lipid/peptide
ratios allowed the calculation of DH, DS, and DG of
the process. A typical experiment is shown in Fig. S6.
When LUVs were composed of SM and Chol only, in the
absence of negatively charged lipids, no measurable heats
of interaction were observed. This may be related to the
relatively poor insertion of Ab into SM/Chol monolayers
described previously, particularly at initial lateral pressures
close to 30 mN/m, that are considered to represent the
average lateral pressure in cell membranes (Fig. 4 B).
Reliable measurements were obtained however with LUV
containing DMPA. The experimental values are summa-
rized in Table 1 (Nos. 1–4). The peptide association constant
(Ka) decreases regularly (and correspondingly DG is made
less negative) when DMPA concentration increases from
2.5 to 20 mol % (Fig. S7). This is in full agreement with
the surface pressure measurements of peptide insertion
(Fig. 4 B).
DMPA has been used throughout this work as a represen-
tative of the structurally simplest class of phospholipids
with a net negative charge being in the fluid phase at
37C. To discard that the observed increased binding was
specific for DMPA, a structurally very different lipid, also
negatively charged, namely CL was used (Table 1, Nos. 5,
6). The presence of CL favored Ab42 interaction
with bilayers even more than DMPA, and again the phenom-
enon was observed that the high CL concentration wasBiophysical Journal 103(3) 453–463
FIGURE 6 Difference IR spectra of Ab42 in mixtures with multilamellar
vesicles (MLV) of varying lipid compositions. Spectra of free peptide
were subtracted from spectra of MLV-peptide mixtures. MLV composition
was: 1, SM/Chol (1/1); 2, SM/Chol/DMPA (47.5/47.5/5); 3, SM/Chol/
DMPA (40/40/20). Lipid/protein mol ratio was 200:1 at 80 mM Ab42.
Binding of Ab42 Peptide to Negatively Charged Membranes 459less effective than the lower one in promoting peptide
binding.
All the above mixtures give rise to bilayers in the Lo state.
With the aim of testing the influence of membrane order on
Ab42 binding a number of experiments were performed
with Ld bilayers (Table 1, Nos. 7–9). The results clearly
show that these membranes bound Ab42 monomers with
higher activity than those in the Lo phase (Table 1, Nos.
1–6). Even pure PC bilayers bound the peptide. However,
in this case the presence of DMPA increased only moder-
ately, by two- to threefolds, the Ka and high DMPA concen-
trations did not appear to cause a large decrease in binding.
ThT assays
ThT fluorescence increases with b-sheet contents of
peptides (40). In our case the test was applied to SM/Chol
mixtures with or without DMPA. The results are summa-
rized in Fig. 5. b-sheet formation increased with time,
DMPA favored the process, and DMPA was more effective
at 5 mol % than at 20 mol %, in good agreement with the
calorimetric and surface pressure results. These data also
corroborate the recent observation by Sani et al. (18) that
negatively charged surfaces favored the Ab peptide transi-
tion to an aggregated b-sheet conformation.
Secondary structure measurements
Formation of b-sheet structures upon binding of Ab42 to
bilayers was directly demonstrated by IR spectroscopy.
The spectra were recorded under conditions similar to those
in the ThT experiments, i.e., 1:200 peptide/lipid mol ratio.
The spectral region corresponding to the amide I band of
Ab42 is shown in Fig. 6. An almost exclusively b-sheet
structure was seen in all cases, as shown by the bands
centered at 1626 cm1 (41), however the intensity increased
in the order: SM/Chol < SM/Chol/DMPA (20 mol %) <
SM/Chol/DMPA (5 mol %), in agreement with all the
results discussed previously.Time (h)
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FIGURE 5 Time course of ThT fluorescence in the presence of Ab42 in
mixtures with LUV of varying lipid compositions. Lipid/protein mol ratio
was 200:1, at 5 mM Ab42. Average values mean5 SE (n ¼ 3).DISCUSSION
The main results in this work include the thermodynamic
parameters of Ab42 monomer peptide binding to lipid bila-
yers in the fluid-ordered and fluid-disordered states, in the
presence and absence of negatively charged lipids. Compa-
rable experiments have been performed using MD methods.
These, together with a number of other techniques, e.g.,
fluorescence and IR spectroscopy, and Langmuir through
measurements, cooperate in providing a rather detailed
picture of monomeric Ab42-membrane interactions.
The binding studies have been interpreted in terms of a
two-state model that suits best the experimental results.
However, it should be kept in mind that the phenomena
we observe include at least three states, namely free, bound,
and adsorbed peptide, the bound-adsorbed transition being
kinetically controlled.Ordered versus disordered fluid bilayers
There has been some confusion on whether Lo domains
(rafts) increase or decrease Ab accumulation in membranes.
These experiments have been usually carried out by
increasing or decreasing cholesterol contents in bilayers
thus increasing or decreasing Lo domain formation. In
some cases Ab accumulation has been related to the pres-
ence of cholesterol (42) and lipid rafts (4). Cholesterol-
rich regions of hippocampal cell membranes have been
associated with increased Ab formation (43). However,
other authors challenge the significance of the previous
experiments, suggesting that APP was overexpressed in
those models. In mice (44) and AD patients (45) inhibition
of cholesterol synthesis or depletion of membrane choles-
terol contents actually led to an increased deposition of
Ab aggregates. In our opinion, the previous studies (4,42–
45) are in fact measuring the joint result of two different
processes, namely APP hydrolysis by b- or g-secretaseBiophysical Journal 103(3) 453–463
460 Ahyayauch et al.yielding Ab42, and Ab deposition and aggregation. b-secre-
tase appears to be located preferentially in Lo domains
(4,46,47), thus Ab is probably generated in those domains,
but deposition and aggregation may occur in different
domains. In this study Ab binding to fluid-ordered bilayers
was studied in particular detail, because of the association of
b-secretase to that sort of domains. Particular care was taken
to ensure that Ab in the monomeric form was initially added
to the membrane suspension, thus in our case only the
process of peptide binding to membranes was considered,
irrespective of the locus or rate of Ab generation. Interest-
ingly, the Ab42 affinity for Ld membranes was higher
than that for the Lo environment in which it is originally
generated.The role of anionic phospholipids
Data in the literature suggest that negatively charged
phospholipids increase Ab fibrillization (18,19). Electro-
static forces help to stabilize Ab-lipid interactions (40,42).
Our measurements (Table 1) confirm the previous observa-
tions, but both the calorimetric and MD results indicate that
binding does not increase linearly with the amount of
negative charges. Rather, a low dose of anionic phospho-
lipids (2.5–5 mol % phosphatidic acid (PA) or CL) increase
notoriously peptide binding, but higher doses have a smaller
effect that MD pictures attribute to overall repelling
electrostatic interactions: only Lys-28 appears to have
a positive interaction with the anionic lipids (21). The latter
authors observed a dose-dependent increase in Ab
binding to PC bilayers containing increasing proportions
(0–50 mol %) of PA. The discrepancy may be because
Chauhan et al. (19) used fluid-disordered bilayers in their
experiments, in our hands high proportions of PA did not
vary much the Ab association constant to the fluid-disor-
dered bilayers. It should also be noted that those authors
measured Ab binding with an indirect method, based on
fluorescent probes. The available results may be summa-
rized by stating that anionic phospholipids do increase Ab
binding both to fluid-ordered and to fluid-disordered
bilayers, although the dose-effect pattern appears to be
a complex one.The view of molecular dynamics
The results obtained from 100 ns MD simulation of Ab42 on
the 512 lipid bilayers provide insights into interactions
occurring between Ab42 and the surface of the heteroge-
neous lipid bilayer. The Ab42 conformational transitions
observed during the MD simulations indicate that 100 ns
is a sufficient simulation time. We are aware of the fact
that 100 ns simulation is not sufficient to sample all avail-
able conformations of Ab42. However, our results are
consistent and in a reasonable agreement with the experi-
mental data and, therefore, allow us to make some generalBiophysical Journal 103(3) 453–463explanations. The previous simulations of Ab42 show that
while in aqueous solution Ab42 undergoes conformational
flexibility (48), in near-homogeneous 128 lipid bilayers,
represented by DPPC and dioleoyl phosphatidlyserine, the
Ab42 peptide adopts a more ordered secondary structure
(20,21).
Analysis of the structure and interactions in model B,
containing 5% DMPA (Fig. 1, Fig. S2) suggests that the
Ab42 peptide associates with the surface of the phospho-
lipid membrane, forming multiple interactions mainly
with the PSM polar head groups. The association results
in a change of the Ab42 secondary structure and an increase
of the radius of gyration in model B compared to model C.
Cluster analysis of the Ab42 backbone structures during the
simulation revealed that the most frequently occurring
secondary structure conformation is similar to the b-hairpin
conformer of Ab42. This is in agreement with the mecha-
nism of the accelerated surface Ab42 fibril formation
proposed by Bokvist et al. (35) and also with the MD study
of Ab42 in the presence of DPPC and dioleoyl phosphati-
dlyserine at different pH performed by Davies et al. (21).
A different behavior of Ab42 is observed for model C
containing 20% DMPA. A distinctly lower number of inter-
actions occur between Ab42 and the phospholipids (Figs. 2
and 3). It was suggested (21) that Lys-28 may play a role in
anchoring the Ab42 to the bilayer. The interactions formed
by Asp-1 and Lys-28 are strong enough to keep the peptide
close to the surface, but in contrast to the B model, the
peptide does not adsorb on it. We believe that unfavorable
electrostatic interactions between the phospholipid head
group of DMPA and Ab42 inhibit binding of Ab42 on the
membrane. These results suggest that an inhibiting role of
DMPA depends on charge density on bilayer surface (in
other words on the molar ratio of DMPA). Whereas 5% of
DMPA support binding of Ab42, the percentage of 20%
prevents strong binding. The intramolecular interactions in
the peptide maintain a somewhat helical conformation
with a markedly smaller radius of gyration than in the B
model. In contrast to the B and C models, in the A model
containing no negatively charged lipids, no interactions
between the protein and the membrane surface were
observed. The protein remains apart from the surface, with
strong intramolecular hydrogen bonding network governing
the conserved secondary structure. Overall, ours and
previous simulation results (20,21) indicate that the binding
and fibril formation on the membrane surface depends on
the bilayer composition, and is the result of a subtle balance
of many inter- and intramolecular interactions between
Ab42 and the membrane. On one hand, intramolecular
hydrogen bonds (e.g., Asp-23-Lys-28) are essential for the
formation of a secondary structure of Ab42. However, an
intermolecular hydrogen bond of Lys-28 is responsible for
holding of Ab42 on the bilayer surface. The previously
mentioned intermolecular electrostatic interactions and
hydrophobic interaction between the hydrophobic core of
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Binding of Ab42 Peptide to Negatively Charged Membranes 461Ab42 and bilayer contribute to this balance. In Fig. S3, the
negatively charged DMPA lipids are color-coded red, and
negatively charged residues of Ab42 are in red, and posi-
tively charged residues in blue. A difference between the
A, B, and C models can be clearly seen. At the beginning,
long-range (electrostatic) interactions are important for
bringing Ab42 close to a bilayer. In the A model, these inter-
actions are not available and Ab42 remains apart from the
bilayer. The situation is different in bilayer models contain-
ing DMPA. Attractive electrostatic interactions between
negative charges of the DMPA phosphate group and positive
charges of the Lys residues are responsible for bringing
Ab42 to the bilayer. Short-range (hydrogen bonding, hydro-
phobic) interactions then start to play a crucial role. In the
B model, hydrophobic interactions between the bilayer
and the C- and N-terminus of Ab42 drive the conforma-
tional change of Ab42 and its position on the bilayer
surface. The hydrogen bond between Lys-28 and PSM
contributes to this process. In the case of the C model, the
electrostatic interactions are stronger compared to the B
model, and as a result, Ab42 is approaching locations
with excessive negative charge density. However, repulsive
electrostatic interactions of crowded DMPA negative
charges with Asp negative charges of Ab42 prevent Ab42
from coming closer to the bilayer. As a consequence, the
hydrogen bond between Lys-28 and phosphate of DMPA
is holding Ab42 close to a bilayer but hydrophobic interac-
tions are too weak to initiate the transformation of the Ab42
secondary structure.DMPA (mol %)
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FIGURE 7 A comparison of data concerning Ab42 binding to bilayers
composed of SM/Chol (1:1 mol ratio), to which increasing amounts of
anionic phospholipid (phosphatidic acid) had been added. (A) MD calcula-
tions of average H-bonds established between peptide and membrane for
the last 20 ns. Data taken from Fig. 2 B. (B) Langmuir balance. Increase
in surface pressure of lipid monolayers (16 mN/m) of the compositions
given previously due to the presence of Ab42. Data are taken from Fig. 4
B. (C) Relative change in intensity of the IR band centered at
1622 cm1, assigned to antiparallel b-sheet vibration. Data taken from
Fig. 6. (D) Changes in ThT fluorescence after 6 h incubation with Ab42
and LUVs. Data taken from Fig. 5.Concluding remarks
The simulations and experiments described previously
concur in showing that, for Ab monomers interacting with
lipid bilayers based on SM and Chol, which are in the Lo
state, the presence of negatively charged phospholipids
facilitates interaction with the Ab peptide. However, low
(2.5–5 mol %) DMPA or CL allows better interaction than
20 mol % of the same lipid. MD calculations predict for
model B (5% DMPA) a larger number of interactions
between peptide and bilayer than in model C (20%
DMPA) or model A (no DMPA). Correspondingly, ThT
fluorescence and IR spectroscopy show that b-sheet forma-
tion by Ab42 occurs more readily at 5% than at 20%DMPA.
Moreover, the MD methods indicate the development of a
b-sheet structure by the peptide in bilayers containing 5%
PA, whereas in the presence of 20 mol % PA the peptide
retains a partially helical conformation. This may lead,
under equilibrium conditions, to the situation of maximum
b-sheet at low DMPA concentrations observed by ITC,
Langmuir trough, and spectroscopic measurements
(Fig. 7). It is also important that when Ab42 interacts with
bilayers in the Ld state, binding is stronger and less depen-
dent on negatively charged lipids than with Lo bilayers.
Our studies refer to Ab42 binding to membranes irrespec-tive of the place where the peptide has been generated. In
principle, there would be no obstacle for Ab42 being
synthesized in Lo domains, yet binding preferentially and
eventually giving rise to plaques, in the Ld regions that are
predominant in cell membranes.Biophysical Journal 103(3) 453–463
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